Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
35 participants
INTERVENTIONAL
2014-07-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Skin Incision Adhesive in Pediatrics
NCT01514396
Case Series Assessing TissuGlu® Surgical Adhesive in Flap Surgery for Decubitus Repair
NCT03482999
A Post-Market Study of BandGrip in Traumatic Wound Closure Compared to Suture
NCT03628690
Evaluation of Zip Device to Conventional Sutures for Laceration Repair in Pediatrics in an Emergency Department
NCT04122859
Study to Show Equivalence of DERMABOND PROTAPE to DERMABOND HVD for Wound Closure
NCT00547638
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Skin Affix
Surgical adhesive
Skin Affix
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Skin Affix
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Requires the use of a surgical skin adhesive
* Informed consent signed
Exclusion Criteria
* Hx keloid formation, hypotension, diabetes, blood clotting disorders
* Wound infections
* mucosal surfaces or skin exposed to body fluids
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medline Industries
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jon Schrock, MD
Role: PRINCIPAL_INVESTIGATOR
Metro Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MetroHealth System
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R14-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.